Belinda Schludi
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Coronary Interventions and Diagnostics, Computational Drug Discovery Methods, Acute Myocardial Infarction Research
Most-Cited Works
- → Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes(2017)24 cited
- → Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials(2022)8 cited
- → Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank(2019)4 cited
- → STATIN TREATMENT PATTERNS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN AN INTEGRATED HEALTHCARE SYSTEM(2020)1 cited
- → A GENERATIVE PRE-TRAINED TRANSFORMER (GPT) MODEL TO PREDICT MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH ELEVATED LIPOPROTEIN(A) AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE(2025)
- → STATIN TREATMENT AND RISK OF CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH MYOCARDIAL INFARCTION IN AN INTEGRATED HEALTHCARE SYSTEM(2020)
- → Abstract 4142745: Lipoprotein(a) distribution across autoimmune inflammatory diseases: a pooled analysis from 28 Phase III clinical trials(2024)
- → Time-Averaged LDL-C Lowering with Evolocumab: Pooled Analysis of Phase 2 Trials(2022)
- → BASELINE CARDIOVASCULAR RISK FOR PATIENTS WITH RECENT MYOCARDIAL INFARCTION PRESCRIBED A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITOR(2020)